Danish company making progress in Merck-deal

Nordic Bioscience is currently carrying out extensive phase II trials that the Danish company has to conduct for Merck Serono in accordance with a partnership deal.

Photo: Merck Serono/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles